Lower dose for days 1-15, then doubled dose for days 16-30
Ongoing investigation into GLP-1 therapies is reflected in this clinical trial listing
Regarding secondary outcomes, four out of five selected trials reported a significant reduction in body weight, BMI, and glycated hemoglobin levels in GLP-1 receptor agonist-treated participants
19,67,73,74 Newly proliferated reactive astrocytes form borders that separate damaged, inflamed, and fibrotic tissue from adjacent viable neural tissue, and during this border formation newly proliferated astrocytes become transcriptionally reprogrammed to adopt new cellular interactions with non-neural cells
RNA isolation and quantitative RT-PCR gene expression levels The total RNA from the kidney tissue was isolated using the TRIzol reagent (Invitrogen) [27], and the cDNA was synthesized following the manufacturers protocol, using 1 g RNA (Prime ScriptTM RT reagent Kit, Takara)